Median time to type 1 diabetes diagnosis 48.4 months with teplizumab and 24.4 months with placebo

One-third of participants progressed to diabetes or died within the 12-year follow-up

Second study shows reduction in renal outcomes with dulaglutide in type 2 diabetes

Children of obese women with gestational diabetes have increased risk for childhood obesity

Intake of vitamins B2, B6 linked to reduced risk for T2DM; B12 intake from food linked to higher risk

Odds higher in two cross-sectional, prospective analyses after adjustment for sleep-related factors

Diabetes mellitus, heart failure often occur concurrently, with each increasing risk of the other

No significant difference in risk for type 2 diabetes seen for those receiving vitamin D, placebo

Genetic, early-life familial environmental factors seem not to contribute to link

Higher number of nerve lesions, declining nerve conduction velocities and amplitudes seen